U.S., Nov. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07242664) titled 'Clamp Study to Estimate the Relative Potency of GZR33 Versus Insulin Degludec at Steady State' on Nov. 17.
Brief Summary: This trial intends to investigate the pharmacodynamics, pharmacokinetics, safety, and tolerability of insulin GZR33 (hereafter referred to as GZR33) and estimate its potency in comparison with insulin degludec.
Study Start Date: Oct. 13
Study Type: INTERVENTIONAL
Condition:
Type 1 Diabetes Mellitis
Intervention:
DRUG: GZR-33
GZR33 is a long-acting basal insulin analogue
Recruitment Status: RECRUITING
Sponsor: Gan and Lee Pharmaceuticals, USA
Disclaimer: Curated by HT Syndication....